| pubmed-article:1153409 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1153409 | lifeskim:mentions | umls-concept:C0012984 | lld:lifeskim |
| pubmed-article:1153409 | lifeskim:mentions | umls-concept:C2709248 | lld:lifeskim |
| pubmed-article:1153409 | lifeskim:mentions | umls-concept:C0598051 | lld:lifeskim |
| pubmed-article:1153409 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:1153409 | lifeskim:mentions | umls-concept:C0138726 | lld:lifeskim |
| pubmed-article:1153409 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:1153409 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:1153409 | pubmed:dateCreated | 1975-10-21 | lld:pubmed |
| pubmed-article:1153409 | pubmed:abstractText | The effects of four F series prostaglandins on the pulmonary vascular bed were compared under conditions of controlled pulmonary blood flow in the intact spontaneously breathing dog. PGF1alpha and PGF2alpha increased lobar arterial pressure whereas PGF1beta and PGF2beta had little if any effect when infused into the lobar artery. The increase in lobar arterial pressure in response to PGF1alpha and PGF2alpha was associated with a significant increase in lobar venous pressure but no change in left atrial pressure. These data indicate that PGF1alpha and PGF2alpha increase pulmonary vascular resistance by constricting lobar veins and vessels upstream to small veins, presumed to be small arteries. It is concluded that in the pulmonary vascular bed the configuration of the hydroxyl group at carbon 9 is an important determinant of pressor activity. | lld:pubmed |
| pubmed-article:1153409 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1153409 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1153409 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1153409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1153409 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1153409 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:1153409 | pubmed:issn | 0037-9727 | lld:pubmed |
| pubmed-article:1153409 | pubmed:author | pubmed-author:KadowitzP JPJ | lld:pubmed |
| pubmed-article:1153409 | pubmed:author | pubmed-author:HymanA LAL | lld:pubmed |
| pubmed-article:1153409 | pubmed:author | pubmed-author:JoinerP DPD | lld:pubmed |
| pubmed-article:1153409 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1153409 | pubmed:volume | 149 | lld:pubmed |
| pubmed-article:1153409 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1153409 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1153409 | pubmed:pagination | 356-61 | lld:pubmed |
| pubmed-article:1153409 | pubmed:dateRevised | 2007-11-2 | lld:pubmed |
| pubmed-article:1153409 | pubmed:meshHeading | pubmed-meshheading:1153409-... | lld:pubmed |
| pubmed-article:1153409 | pubmed:meshHeading | pubmed-meshheading:1153409-... | lld:pubmed |
| pubmed-article:1153409 | pubmed:meshHeading | pubmed-meshheading:1153409-... | lld:pubmed |
| pubmed-article:1153409 | pubmed:meshHeading | pubmed-meshheading:1153409-... | lld:pubmed |
| pubmed-article:1153409 | pubmed:meshHeading | pubmed-meshheading:1153409-... | lld:pubmed |
| pubmed-article:1153409 | pubmed:meshHeading | pubmed-meshheading:1153409-... | lld:pubmed |
| pubmed-article:1153409 | pubmed:meshHeading | pubmed-meshheading:1153409-... | lld:pubmed |
| pubmed-article:1153409 | pubmed:meshHeading | pubmed-meshheading:1153409-... | lld:pubmed |
| pubmed-article:1153409 | pubmed:meshHeading | pubmed-meshheading:1153409-... | lld:pubmed |
| pubmed-article:1153409 | pubmed:meshHeading | pubmed-meshheading:1153409-... | lld:pubmed |
| pubmed-article:1153409 | pubmed:meshHeading | pubmed-meshheading:1153409-... | lld:pubmed |
| pubmed-article:1153409 | pubmed:meshHeading | pubmed-meshheading:1153409-... | lld:pubmed |
| pubmed-article:1153409 | pubmed:year | 1975 | lld:pubmed |
| pubmed-article:1153409 | pubmed:articleTitle | Comparison of the effects of prostaglandins F1alpha, F2alpha, F1beta, and F2beta on the canine pulmonary vascular bed. | lld:pubmed |
| pubmed-article:1153409 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1153409 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1153409 | lld:pubmed |
